Assenagon Asset Management S.A. Lowers Position in Corteva, Inc. $CTVA

Assenagon Asset Management S.A. cut its stake in shares of Corteva, Inc. (NYSE:CTVA) by 67.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 903,046 shares of the company’s stock after selling 1,848,111 shares during the period. Assenagon Asset Management S.A. owned about 0.13% of Corteva worth $60,531,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Activest Wealth Management raised its holdings in shares of Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after purchasing an additional 200 shares during the last quarter. JPL Wealth Management LLC bought a new position in shares of Corteva during the third quarter valued at about $25,000. True Wealth Design LLC boosted its holdings in Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after purchasing an additional 264 shares during the last quarter. Total Investment Management Inc. bought a new stake in Corteva in the 2nd quarter worth about $27,000. Finally, Twin Peaks Wealth Advisors LLC bought a new stake in Corteva in the 2nd quarter worth about $29,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Price Performance

Shares of NYSE:CTVA opened at $80.46 on Wednesday. The firm has a market capitalization of $54.01 billion, a PE ratio of 50.92, a P/E/G ratio of 2.66 and a beta of 0.72. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The company has a 50-day moving average price of $75.51 and a two-hundred day moving average price of $69.44. Corteva, Inc. has a twelve month low of $53.40 and a twelve month high of $81.12.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts forecast that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were issued a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s payout ratio is presently 45.57%.

Insider Activity

In other Corteva news, insider Brian Titus sold 8,311 shares of the stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider owned 8,090 shares in the company, valued at $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.15% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have commented on CTVA shares. Wolfe Research lifted their target price on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Argus raised Corteva to a “strong-buy” rating in a research report on Friday, January 16th. Deutsche Bank Aktiengesellschaft lifted their price target on Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Weiss Ratings reissued a “hold (c-)” rating on shares of Corteva in a research report on Monday, December 29th. Finally, CICC Research upped their price objective on Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a research note on Wednesday, February 11th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $82.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.